Submit Manuscript  

About the Journal

Aims & Scope

Current Pharmacogenomics and Personalized Medicine (CPPM) is a transdisciplinary peer-reviewed biomedical journal that reports new findings and cutting-edge concepts in both pharmacogenomics and personalized medicine under a single cover. CPPM is an accelerator for global personalized medicine and pharmacogenomics. Importantly, the journal provides a multi-disciplinary integrated platform from cell to society to address diagnostics and responsible pharmacogenomics applications in developing countries.
Read More

Editorial Board Members

Ranking and Category

Latest Articles


"Current Pharmacogenomics and Personalized Medicine provides access to the most recent progress and opinion in this rapidly developing field and is an indispensable source of information for scientists and clinicians who want to keep in touch with the expanding interdisciplinary advancements."

Brian Tomlinson
Professor of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR.

"Current Pharmacogenomics and Personalized Medicine provides interdisciplinary and integrative perspectives on most recent advances in personalized medicine. The scope of diseases and pharmaceutical outcomes covered is broad and timely. I believe the journal is an essential reading for anyone who aims to quickly grasp the cutting edge in pharmacogenomics and predictive medicine."

Sunao Kaneko
President, Japanese Society of Clinical Neuropsychopharmacology.
"Expert Reviews in Current Pharmacogenomics and Personalized Medicine present complicated disease processes and their treatment options in a succinct manner. They are an invaluable resource for both clinicians and biomedical scientists."

Judy Wong
Canada Research Chair in Genome Maintenance, University of British Columbia, Vancouver, Canada
"Current Pharmacogenomics and Personalized Medicine integrates the advances across therapeutic areas as well as molecular, clinical and social sciences. I believe the journal will contribute to the new interdisciplinary field of personalized medicine to gain its identity and accelerate its evolution."

S. Oguz Kayaalp
Professor of Pharmacology and Honorary Member, The Turkish Academy of Sciences, Ankara, Turkey


submit research paper with Bentham Science Publisher

About the Publisher

Bentham Science: An Introduction

We have been serving the needs of STM field since 1992 and publish 117 titles, fulfilling the information needs for the Pharmaceutical and Biomedical research community. We are publishers of many high impact factor Journals and eBooks.

Subscription Information:

All Journals are available online. For information on the Journals and how to order, please visit our web site at: and select "Prices and Ordering" or contact our subscription department at:

Open Access:

Bentham Science currently offers authors the choice of publishing their articles as open access. Please refer to the Journal instructions for authors for details.

Indexed In

Cabell's Directory,2